parenteral factor XIa inhibitor (Bristol-Myers Squibb)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameparenteral factor XIa inhibitor (Bristol-Myers Squibb)
Drug Alias NameFactor XIa Inhibitor (BMS)BMS-724296
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A